ASX - By Stock
|
WBT |
Re:
Ann: Suspension from Official Quotation
|
|
AndyG83
|
300 |
107K |
3 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
300
|
107K
|
3
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano successfully qualifies its ReRAM module
|
|
AndyG83
|
160 |
89K |
47 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
160
|
89K
|
47
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Presentation at Goldman Sachs Emerging Technology Conference
|
|
AndyG83
|
14 |
7.8K |
33 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
14
|
7.8K
|
33
|
|
ASX - By Stock
|
PNV |
Re:
Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial
|
|
AndyG83
|
50 |
17K |
8 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
50
|
17K
|
8
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
AndyG83
|
10K |
4.7M |
5 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
10K
|
4.7M
|
5
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit tapes out ReRAM demo chip to SkyWater foundry
|
|
AndyG83
|
60 |
33K |
21 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
60
|
33K
|
21
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
AndyG83
|
2.9K |
1.3M |
18 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
18
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2022 and beyond
|
|
AndyG83
|
2.9K |
1.3M |
15 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
2.9K
|
1.3M
|
15
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano Q2 FY22 Activities Report and Appendix 4C
|
|
AndyG83
|
36 |
18K |
52 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
36
|
18K
|
52
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
AndyG83
|
850 |
246K |
6 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
246K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
AndyG83
|
850 |
246K |
22 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
246K
|
22
|
|
ASX - By Stock
|
EML |
Re:
Ann: Central Bank of Ireland Update
|
|
AndyG83
|
120 |
43K |
7 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
120
|
43K
|
7
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
AndyG83
|
10K |
3.6M |
0 |
12/11/21 |
12/11/21 |
ASX - By Stock
|
10K
|
3.6M
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
AndyG83
|
10K |
3.6M |
0 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
10K
|
3.6M
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Trading halt
|
|
AndyG83
|
185 |
74K |
14 |
08/11/21 |
08/11/21 |
ASX - By Stock
|
185
|
74K
|
14
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
AndyG83
|
10K |
3.6M |
8 |
04/11/21 |
04/11/21 |
ASX - By Stock
|
10K
|
3.6M
|
8
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
AndyG83
|
10K |
3.6M |
1 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
10K
|
3.6M
|
1
|
|
ASX - By Stock
|
EML |
Re:
Ann: Central Bank of Ireland Update
|
|
AndyG83
|
312 |
127K |
18 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
312
|
127K
|
18
|
|
ASX - By Stock
|
EML |
Re:
Ann: Central Bank of Ireland Update
|
|
AndyG83
|
312 |
127K |
37 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
312
|
127K
|
37
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
AndyG83
|
10K |
3.6M |
2 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
10K
|
3.6M
|
2
|
|
ASX - By Stock
|
WBT |
Re:
Pitt Street Research Update
|
|
AndyG83
|
2 |
2.3K |
3 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
2
|
2.3K
|
3
|
|
ASX - By Stock
|
WBT |
Re:
Short data on WBT
|
|
AndyG83
|
2.3K |
859K |
7 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
2.3K
|
859K
|
7
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit signs first commercial deal with US-based SkyWater
|
|
AndyG83
|
698 |
276K |
11 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
698
|
276K
|
11
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit signs first commercial deal with US-based SkyWater
|
|
AndyG83
|
698 |
276K |
4 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
698
|
276K
|
4
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
AndyG83
|
10K |
3.6M |
15 |
05/09/21 |
05/09/21 |
ASX - By Stock
|
10K
|
3.6M
|
15
|
|
ASX - By Stock
|
WBT |
Re:
Commercial Partnership[!!
|
|
AndyG83
|
484 |
243K |
4 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
484
|
243K
|
4
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Appendix 4E and Annual Report
|
|
AndyG83
|
48 |
17K |
0 |
27/08/21 |
27/08/21 |
ASX - By Stock
|
48
|
17K
|
0
|
|
ASX - By Stock
|
PBH |
Re:
Ann: PBH Appointed NFL Approved Sportsbook Operator
|
|
AndyG83
|
55 |
15K |
2 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
55
|
15K
|
2
|
|
ASX - By Stock
|
PBH |
Re:
Ann: PBH Appointed NFL Approved Sportsbook Operator
|
|
AndyG83
|
55 |
15K |
3 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
55
|
15K
|
3
|
|
ASX - By Stock
|
EML |
Re:
Ann: Injection of funds in PFSUK safeguarding accounts
|
|
AndyG83
|
24 |
9.3K |
0 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
24
|
9.3K
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Q4 FY21 business update & meet the Chair & CEO event details
|
|
AndyG83
|
53 |
22K |
12 |
22/07/21 |
22/07/21 |
ASX - By Stock
|
53
|
22K
|
12
|
|
ASX - By Stock
|
EML |
Re:
Ann: Central Bank of Ireland correspondence
|
|
AndyG83
|
347 |
165K |
7 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
347
|
165K
|
7
|
|
ASX - By Stock
|
WBT |
Re:
Frost & Sullivan Research Initiation Report for Weebit Nano (ASX: WBT)
|
|
AndyG83
|
127 |
50K |
0 |
17/03/21 |
17/03/21 |
ASX - By Stock
|
127
|
50K
|
0
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Q2 FY21 Investor Presentation
|
|
AndyG83
|
46 |
15K |
0 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
46
|
15K
|
0
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Q2 FY21 Investor Presentation
|
|
AndyG83
|
46 |
15K |
0 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
46
|
15K
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano Q2 FY21 Activities Report and Appendix 4C
|
|
AndyG83
|
132 |
43K |
3 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
132
|
43K
|
3
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Q2 FY21 Investor Presentation
|
|
AndyG83
|
46 |
15K |
8 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
46
|
15K
|
8
|
|
ASX - By Stock
|
PBH |
Re:
Ann: ZSP: Saracen Mineral to be removed from the S&P/ASX Indices
|
|
AndyG83
|
16 |
6.7K |
0 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
16
|
6.7K
|
0
|
|
ASX - By Stock
|
PBH |
Re:
Ann: ZSP: Saracen Mineral to be removed from the S&P/ASX Indices
|
|
AndyG83
|
16 |
6.7K |
1 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
16
|
6.7K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit successfully completes $3 million Share Purchase Plan
|
|
AndyG83
|
168 |
44K |
22 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
168
|
44K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
|
|
AndyG83
|
572 |
250K |
26 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
572
|
250K
|
26
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2021and beyond
|
|
AndyG83
|
10K |
3.6M |
6 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
10K
|
3.6M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
AndyG83
|
13K |
4.9M |
4 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
4.9M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
AndyG83
|
13K |
4.9M |
3 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
4.9M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
AndyG83
|
23K |
13M |
2 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Investor Presentation - Q4 FY20
|
|
AndyG83
|
39 |
22K |
4 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
39
|
22K
|
4
|
|
ASX - By Stock
|
PBH |
Re:
Ann: Investor Presentation - Q4 FY20
|
|
AndyG83
|
39 |
22K |
2 |
28/07/20 |
28/07/20 |
ASX - By Stock
|
39
|
22K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
AndyG83
|
17K |
6.5M |
7 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
17K
|
6.5M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Coming News ???
|
|
AndyG83
|
510 |
221K |
4 |
04/07/20 |
04/07/20 |
ASX - By Stock
|
510
|
221K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
AndyG83
|
23K |
13M |
1 |
03/07/20 |
03/07/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|